Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.7, Iss.11, 2011-11, pp. : 1411-1429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 Part 3: Impact of Drug‐Drug Interactions

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 39, Iss. 1, 2009-03 ,pp. : 55-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug-Drug Interactions of Triazole Antifungal Agents in Multimorbid Patients and Implications for Patient Care

Current Drug Metabolism, Vol. 10, Iss. 4, 2009-05 ,pp. : 395-409

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet Drug Resistance and Drug-Drug Interactions: Role of Cytochrome P450 3A4

By Lau Wei Gurbel Paul

Pharmaceutical Research, Vol. 23, Iss. 12, 2006-12 ,pp. : 2691-2708

Springer Publishing Company

Access to resources Recommend Favorite

The role of cytochrome P450 in antiretroviral drug interactions

By Walubo Andrew

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 4, 2007-08 ,pp. : 583-598

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450-mediated cardiovascular drug interactions

By Scheen André J

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1065-1082

Informa Healthcare

Access to resources Recommend Favorite